Michael G. Kelly

Chief Scientific Officer at CureDuchenne

Michael G. Kelly

Michael G. Kelly

Chief Scientific Officer at CureDuchenne

Overview
Career Highlights

MyoTherix, Inc.

RelSci Relationships

1418

Number of Boards

2

Relationships
RelSci Relationships are individuals Michael G. Kelly likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at MyoTherix, Inc.

Relationship likelihood: Strong

Founder at CureDuchenne

Relationship likelihood: Strong

Founder at CureDuchenne

Relationship likelihood: Strong

Treasurer at MyoTherix, Inc.

Relationship likelihood: Strong

Treasurer & Director at CureDuchenne

Relationship likelihood: Strong

Chief Executive Officer at Cyto-Sen Therapeutics, Inc.

Relationship likelihood: Strong

Head-Business Development at CureDuchenne

Relationship likelihood: Strong

Head-Marketing at CureDuchenne

Relationship likelihood: Strong

Senior Director-Development at CureDuchenne

Relationship likelihood: Strong

Vice President-Marketing Communications at CureDuchenne

Relationship likelihood: Average

Paths to Michael G. Kelly
Potential Connections via
Relationship Science
You
Michael G. Kelly
Chief Scientific Officer at CureDuchenne
Education

Southampton Engineering is a Construction company located in 30 Flying Goose Path, Water Mill, New York, United States.

University of Ulster is an educational institution that provides undergraduate, postgraduate, and research programs. It offers courses in accounting; biology; engineering; creative technologies; criminology and criminal justice; dance; design for visual communication; English; film studies; and geography. University of Ulster was formerly known as New University of Ulster and changed its name to University of Ulster in January, 1984. The university was founded in 1968 and is based in Coleraine, United Kingdom.

Career History
Chief Scientific Officer
2011 - Current

CureDuchenne provides funding for research projects and organizations. The company was founded in 2003 by Paul Miller and Debra Miller and is located in Newport Beach, CA.

President
Current
Senior Vice President-Research & Development
2003 - Prior

Renovis, Inc. develops pharmaceutical products. The company discovers, develops, and commercializes novel therapeutics for neurological and inflammatory diseases. It is headquartered in San Francisco, CA

Boards & Committees
Director
Current

Myotherix, Inc. operates as a biopharmaceutical company focuses on the development of therapies. It focuses on the development of innovative therapies for patients suffering from Duchenne muscular dystrophy and other muscle disorders for which there are no treatments. The company was founded by John Kincaid and is headquartered in Emeryville, CA.

Director
Prior

NeoGenesis Pharmaceuticals, Inc. used to discover and develop small molecule drugs. The company was founded in 1997 by Allen H. Michels and was headquartered in Cambridge, MA

Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Michael G. Kelly. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Michael G. Kelly's profile does not indicate a business or promotional relationship of any kind between RelSci and Michael G. Kelly.
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/person/michael-g-kelly-246126245
  • https://relationshipscience.com/person/michael-g-kelly-246126245